Deerfield Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $170M | Sell |
9,724,508
-790,149
| -8% | -$13.8M | 3.08% | 7 |
|
|
2025
Q1 | $132M | Hold |
10,514,657
| – | – | 2.61% | 8 |
|
|
2024
Q4 | $111M | Sell |
10,514,657
-563,270
| -5% | -$5.94M | 2.1% | 12 |
|
|
2024
Q3 | $161M | Hold |
11,077,927
| – | – | 2.4% | 7 |
|
|
2024
Q2 | $94.3M | Hold |
11,077,927
| – | – | 1.57% | 20 |
|
|
2024
Q1 | $113M | Hold |
11,077,927
| – | – | 1.97% | 16 |
|
|
2023
Q4 | $60.7M | Hold |
11,077,927
| – | – | 1.12% | 27 |
|
|
2023
Q3 | $41.9M | Hold |
11,077,927
| – | – | 0.92% | 29 |
|
|
2023
Q2 | $74.2M | Hold |
11,077,927
| – | – | 1.58% | 19 |
|
|
2023
Q1 | $72.1M | Hold |
11,077,927
| – | – | 1.61% | 19 |
|
|
2022
Q4 | $94.5M | Buy |
+11,077,927
| New | +$94.5M | 1.96% | 18 |
|